RETRACTABLE TECHNOLOGIES INC
No SEC Form 4 filings for $RVP in the last 30 days.
See all $RVP insider activity →Retractable Technologies (RVP) announced a $1.00 per share dividend, payable October 22 to shareholders of record on October 12, with an ex-dividend date of October 12.
RETRACTABLE TECHNOLOGIES INC (RVP) filed an SEC Form 8-K — Other Events. Exhibit 99 RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B PREFERRED STOCK SHAREHOLDERS LITTLE ELM, Texas, September 30, 2026 — Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has decla
Retractable Technologies, Inc. reported a 15.8% increase in revenues for 2025, reaching $38.3 million, driven by higher domestic and international sales of its medical products. Despite the revenue growth, the company experienced a loss from operations of $21.2 million and incurred $1.8 million in tariff expenses, primarily due to a 120% tariff rate on products imported from China, which accounted for 62.6% of its sourcing. Management anticipates that these tariffs will continue to significantly impact the company's financial performance.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning RVP (RETRACTABLE TECHNOLOGIES INC). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent RVP coverage spans financial news and corporate actions.
Dividend announcement may attract income‑focused buyers, creating modest buying pressure before the ex‑date and potential sell‑off after.
The dividend announcement provides a modest yield to preferred shareholders and may generate slight upward pressure on the stock.
The 120% tariffs on Chinese imports substantially increase costs for RVP, likely exerting downward pressure on profit margins despite revenue growth. The company's stock sentiment is somewhat bearish, reflecting concerns over tariff sustainability and profit margins.
Retractable Technologies (RVP) reported improved Q3 2025 earnings driven by better margins, investment gains, and a shift toward domestic production. The positive earnings report has led to a rise in stock price despite ongoing tariff and cost pressures.
Zacks has initiated coverage of RVP with an 'Underperform' rating, citing financial challenges. This suggests potential downside in RVP's stock price, especially in the short to medium term.
AlphAI scores every news story that mentions RVP with an AI model for sentiment and relevance, and aggregates insider trades from RETRACTABLE TECHNOLOGIES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Retractable Technologies (RVP) announced a $1.00 per share dividend, payable October 22 to shareholders of record on October 12, with an ex-dividend date of October 12.
1 min readRETRACTABLE TECHNOLOGIES INC (RVP) filed an SEC Form 8-K — Other Events. Exhibit 99 RETRACTABLE TECHNOLOGIES, INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B PREFERRED STOCK SHAREHOLDERS LITTLE ELM, Texas, September 30, 2026 — Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has decla
1 min readRetractable Technologies, Inc. reported a 15.8% increase in revenues for 2025, reaching $38.3 million, driven by higher domestic and international sales of its medical products. Despite the revenue growth, the company experienced a loss from operations of $21.2 million and incurred $1.8 million in tariff expenses, primarily due to a 120% tariff rate on products imported from China, which accounted for 62.6% of its sourcing. Management anticipates that these tariffs will continue to significantly impact the company's financial performance.
4 min readRetractable Technologies reports improved third-quarter 2025 earnings driven by better margins, investment gains and a shift toward domestic production.
2 min readDiscover why Zacks rates Retractable Technologies as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore RVP's declining profitability amid rising costs, significant cash concerns and concentration risk.
4 min read
